Literature DB >> 23283818

Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma.

Chen Li1, Lv Ji, Zhong-Yang Ding, Qian-De Zhang, Guo-Rong Huang.   

Abstract

This study aims to investigate the expression and significance of KPNA2 in human gastric adenocarcinoma progression and prognosis. Using immunohistochemistry and real-time reverse transcriptase polymerase chain reaction assay, we identified abnormally elevated expression of KPNA2 in gastric adenocarcinoma tissues compared to paired normal stomach mucosa tissues in 30 patients (p < 0.05). In order to investigate the correlations between KPNA2 and the clinicopathological features of gastric adenocarcinoma, the expression of KPNA2 in 142 patients with gastric adenocarcinoma was detected by immunohistochemistry, and the results showed that overexpression of KPNA2 was associated with the size of tumor (p < 0.001), histological grade (p < 0.001), lymph node involvement (p = 0.001), and tumor node metastasis stage (p < 0.001). Kaplan-Meier survival analysis showed that patients with high KPNA2 expression showed a significantly shorter overall survival time compared with patients with low KPNA2 expression. Multivariate analysis suggested that KPNA2 expression might be an independent prognostic indicator (p < 0.001) for the survival of patients with gastric adenocarcinoma. In conclusion, overexpression of KPNA2 is closely related to progression of gastric adenocarcinoma and might be regarded as an independent predictor of poor prognosis for gastric adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23283818     DOI: 10.1007/s13277-012-0641-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  13 in total

Review 1.  Transport into and out of the nucleus.

Authors:  I G Macara
Journal:  Microbiol Mol Biol Rev       Date:  2001-12       Impact factor: 11.056

Review 2.  Karyopherins and nuclear import.

Authors:  Y M Chook; G Blobel
Journal:  Curr Opin Struct Biol       Date:  2001-12       Impact factor: 6.809

Review 3.  Regulation of nuclear transport: central role in development and transformation?

Authors:  Ivan K H Poon; David A Jans
Journal:  Traffic       Date:  2005-03       Impact factor: 6.215

4.  Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy.

Authors:  Raihanatou Diallo-Danebrock; Evelyn Ting; Oleg Gluz; Alexander Herr; Svjetlana Mohrmann; Helene Geddert; Achim Rody; Karl-Ludwig Schaefer; Stephan E Baldus; Arndt Hartmann; Peter J Wild; Michael Burson; Helmut E Gabbert; Ulrike Nitz; Christopher Poremba
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

5.  Importin alpha transports CaMKIV to the nucleus without utilizing importin beta.

Authors:  Ippei Kotera; Toshihiro Sekimoto; Yoichi Miyamoto; Takuya Saiwaki; Emi Nagoshi; Hiroyuki Sakagami; Hisatake Kondo; Yoshihiro Yoneda
Journal:  EMBO J       Date:  2005-02-17       Impact factor: 11.598

6.  Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Authors:  Véronique Winnepenninckx; Vladimir Lazar; Stefan Michiels; Philippe Dessen; Marguerite Stas; Soledad R Alonso; Marie-Françoise Avril; Pablo L Ortiz Romero; Thomas Robert; Ovidiu Balacescu; Alexander M M Eggermont; Gilbert Lenoir; Alain Sarasin; Thomas Tursz; Joost J van den Oord; Alain Spatz
Journal:  J Natl Cancer Inst       Date:  2006-04-05       Impact factor: 13.506

7.  Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.

Authors:  Oleg Gluz; Peter Wild; Robert Meiler; Raihana Diallo-Danebrock; Evelyn Ting; Svjetlana Mohrmann; Gerhart Schuett; Edgar Dahl; Thomas Fuchs; Alexander Herr; Andreas Gaumann; Markus Frick; Christopher Poremba; Ulrike Anneliese Nitz; Arndt Hartmann
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

8.  KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situ.

Authors:  Anja Dankof; Florian R Fritzsche; Edgar Dahl; Stefan Pahl; Peter Wild; Manfred Dietel; Arndt Hartmann; Glen Kristiansen
Journal:  Virchows Arch       Date:  2007-09-27       Impact factor: 4.064

9.  Polo-like kinase and survivin are esophageal tumor-specific promoters.

Authors:  Fumiaki Sato; John M Abraham; Jing Yin; Takatsugu Kan; Tetsuo Ito; Yuriko Mori; James P Hamilton; Zhe Jin; Yulan Cheng; Bogdan Paun; Agnes T Berki; Suna Wang; Yutaka Shimada; Stephen J Meltzer
Journal:  Biochem Biophys Res Commun       Date:  2006-02-09       Impact factor: 3.575

10.  Karyopherin-alpha2 protein interacts with Chk2 and contributes to its nuclear import.

Authors:  Laura Zannini; Daniele Lecis; Sofia Lisanti; Roberta Benetti; Giacomo Buscemi; Claudio Schneider; Domenico Delia
Journal:  J Biol Chem       Date:  2003-08-09       Impact factor: 5.157

View more
  9 in total

1.  Overexpression of SPAG9 in human gastric cancer is correlated with poor prognosis.

Authors:  Zhi-Feng Miao; Zhen-Ning Wang; Ting-Ting Zhao; Ying-Ying Xu; Jian-Hua Wu; Xing-Yu Liu; Hao Xu; Yi You; Hui-Mian Xu
Journal:  Virchows Arch       Date:  2015-08-21       Impact factor: 4.064

2.  Zika virus NS2A protein induces the degradation of KPNA2 (karyopherin subunit alpha 2) via chaperone-mediated autophagy.

Authors:  Jia He; Liping Yang; Peixi Chang; Shixing Yang; Shaoli Lin; Qiyi Tang; Xinping Wang; Yan-Jin Zhang
Journal:  Autophagy       Date:  2020-09-28       Impact factor: 16.016

3.  KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer.

Authors:  A T Alshareeda; O H Negm; A R Green; C C Nolan; P Tighe; N Albarakati; R Sultana; S Madhusudan; I O Ellis; E A Rakha
Journal:  Br J Cancer       Date:  2015-05-19       Impact factor: 7.640

4.  Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.

Authors:  Yu Zhang; Meng Zhang; Fudong Yu; Su Lu; Huimin Sun; Huamei Tang; Zhihai Peng
Journal:  J Exp Clin Cancer Res       Date:  2015-12-01

5.  Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma.

Authors:  Zhe-Yuan Hu; Sheng-Xian Yuan; Yuan Yang; Wei-Ping Zhou; Hua Jiang
Journal:  J Exp Clin Cancer Res       Date:  2014-07-25

6.  Karyopherin alpha 2 expression is a novel diagnostic and prognostic factor for colorectal cancer.

Authors:  Lei Yu; Guiyu Wang; Qian Zhang; Li Gao; Rui Huang; Yinggang Chen; Qingchao Tang; Jin Liu; Chunjia Liu; Hongwei Wang; Xishan Wang
Journal:  Oncol Lett       Date:  2017-01-10       Impact factor: 2.967

Review 7.  Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis.

Authors:  Li-Na Zhou; Yue Tan; Ping Li; Ping Zeng; Min-Bin Chen; Ye Tian; Ya-Qun Zhu
Journal:  Oncotarget       Date:  2017-01-03

8.  Global gene expression analysis of canine cutaneous mast cell tumor: could molecular profiling be useful for subtype classification and prognostication?

Authors:  Mery Giantin; Anna Granato; Chiara Baratto; Laura Marconato; Marta Vascellari; Emanuela M Morello; Antonella Vercelli; Franco Mutinelli; Mauro Dacasto
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

9.  Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.

Authors:  Jingcheng Zhou; Daoquan Dong; Ran Cheng; Yan Wang; Shuqi Jiang; Yuhong Zhu; Longlong Fan; Xiangming Mao; Yaoting Gui; Zesong Li; Xianxin Li; Bentao Shi
Journal:  Oncotarget       Date:  2016-11-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.